Arvelle is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of central nervous system disorders.
Business Model:
Revenue: $38.9M
Employees: 51-200
Arvelle was acquired by
Angelini Pharma.
The acquisition happend on 2021-01-04.
Details of the transaction were not public
Address: Zahlerweg 6
City: Zug
State: zug
Zip: 6301
Country: CH
Arvelle is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of central nervous system disorders.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|